• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺高血压发生和进展中的表观遗传调控。

Epigenetic Modulation in the Initiation and Progression of Pulmonary Hypertension.

机构信息

From the Department of Pediatrics, (X.C., Y.W.) Children's Hospital of Zhejiang University School of Medicine, Hangzhou, China.

出版信息

Hypertension. 2019 Oct;74(4):733-739. doi: 10.1161/HYPERTENSIONAHA.119.13458. Epub 2019 Sep 3.

DOI:10.1161/HYPERTENSIONAHA.119.13458
PMID:31476913
Abstract

Pulmonary hypertension (PH) is a severe disease with multiple etiologies. In addition to genetics, recent studies have revealed the epigenetic modulation in the initiation and progression of PH. In this review, we summarize the epigenetic mechanisms in the pathogenesis of PH, specifically, DNA methylation, histone modifications, and microRNAs. We further emphasize the diagnostic and therapeutic potential of these epigenetic hallmarks in PH. Finally, we highlight the developmental reprogramming in adult-onset PH because of adverse perinatal exposures such as intrauterine growth restriction and extrauterine growth restriction. Therefore, epigenetic modifications provide promise for the therapy and prevention of PH.

摘要

肺动脉高压(PH)是一种病因多样的严重疾病。除了遗传因素外,最近的研究还揭示了表观遗传调控在 PH 的发生和发展中的作用。在这篇综述中,我们总结了 PH 发病机制中的表观遗传机制,特别是 DNA 甲基化、组蛋白修饰和 microRNAs。我们进一步强调了这些表观遗传特征在 PH 中的诊断和治疗潜力。最后,我们强调了由于宫内生长受限和宫外生长受限等围产期不良暴露导致的成人发病 PH 中的发育重编程。因此,表观遗传修饰为 PH 的治疗和预防提供了希望。

相似文献

1
Epigenetic Modulation in the Initiation and Progression of Pulmonary Hypertension.肺高血压发生和进展中的表观遗传调控。
Hypertension. 2019 Oct;74(4):733-739. doi: 10.1161/HYPERTENSIONAHA.119.13458. Epub 2019 Sep 3.
2
Epigenetic modulation as a therapeutic approach for pulmonary arterial hypertension.表观遗传调控作为肺动脉高压的一种治疗方法。
Exp Mol Med. 2015 Jul 31;47(7):e175. doi: 10.1038/emm.2015.45.
3
Integrating epigenetics and metabolomics to advance treatments for pulmonary arterial hypertension.整合表观遗传学和代谢组学以推进肺动脉高压的治疗
Biochem Pharmacol. 2022 Oct;204:115245. doi: 10.1016/j.bcp.2022.115245. Epub 2022 Sep 10.
4
Intrauterine Growth Restriction Programs Intergenerational Transmission of Pulmonary Arterial Hypertension and Endothelial Dysfunction via Sperm Epigenetic Modifications.宫内生长受限通过精子表观遗传修饰程序性传递肺动脉高压和血管内皮功能障碍的发生。
Hypertension. 2019 Nov;74(5):1160-1171. doi: 10.1161/HYPERTENSIONAHA.119.13634. Epub 2019 Oct 9.
5
Critical effects of epigenetic regulation in pulmonary arterial hypertension.表观遗传调控在肺动脉高压中的关键作用。
Cell Mol Life Sci. 2017 Oct;74(20):3789-3808. doi: 10.1007/s00018-017-2551-8. Epub 2017 Jun 1.
6
The emerging role of epigenetics in pulmonary hypertension.表观遗传学在肺动脉高压中的新兴作用。
Eur Respir J. 2016 Sep;48(3):903-17. doi: 10.1183/13993003.01714-2015. Epub 2016 Aug 4.
7
Insights on the epigenetic mechanisms underlying pulmonary arterial hypertension.肺动脉高压潜在表观遗传机制的见解
Braz J Med Biol Res. 2018 Oct 18;51(12):e7437. doi: 10.1590/1414-431X20187437.
8
Epigenetics: novel mechanism of pulmonary hypertension.表观遗传学:肺动脉高压的新机制。
Lung. 2013 Dec;191(6):601-10. doi: 10.1007/s00408-013-9505-1. Epub 2013 Sep 20.
9
Advances in epigenetic modifications of autophagic process in pulmonary hypertension.肺高血压中自噬过程的表观遗传修饰的研究进展。
Front Immunol. 2023 Jun 16;14:1206406. doi: 10.3389/fimmu.2023.1206406. eCollection 2023.
10
Epigenetic modification: a regulatory mechanism in essential hypertension.表观遗传修饰:原发性高血压的一种调控机制。
Hypertens Res. 2019 Aug;42(8):1099-1113. doi: 10.1038/s41440-019-0248-0. Epub 2019 Mar 13.

引用本文的文献

1
Therapeutic targets for pulmonary arterial hypertension: insights into the emerging landscape.肺动脉高压的治疗靶点:对新出现格局的见解
Expert Opin Ther Targets. 2025 Jun;29(6):327-343. doi: 10.1080/14728222.2025.2507034. Epub 2025 May 21.
2
Promotor Hypomethylation Mediated Upregulation of VCAN Targets Twist1 to Promote EndMT in Hypoxia-Induced Pulmonary Hypertension.启动子低甲基化介导的VCAN上调靶向Twist1以促进缺氧诱导的肺动脉高压中的内皮-间充质转化
J Am Heart Assoc. 2024 Dec 3;13(23):e036969. doi: 10.1161/JAHA.124.036969. Epub 2024 Nov 22.
3
GPS2 ameliorates cigarette smoking-induced pulmonary vascular remodeling by modulating the ras-Raf-ERK axis.
GPS2 通过调节 ras-Raf-ERK 轴改善吸烟诱导的肺血管重构。
Respir Res. 2024 May 16;25(1):210. doi: 10.1186/s12931-024-02831-0.
4
Connexin43, A Promising Target to Reduce Cardiac Arrhythmia Burden in Pulmonary Arterial Hypertension.缝隙连接蛋白 43:降低肺动脉高压性心律失常负担的有前途靶点
Int J Mol Sci. 2024 Mar 14;25(6):3275. doi: 10.3390/ijms25063275.
5
Influence of DNA Methylation on Vascular Smooth Muscle Cell Phenotypic Switching.DNA 甲基化对血管平滑肌细胞表型转化的影响。
Int J Mol Sci. 2024 Mar 8;25(6):3136. doi: 10.3390/ijms25063136.
6
Right Ventricle and Epigenetics: A Systematic Review.右心室与表观遗传学:系统综述。
Cells. 2023 Nov 23;12(23):2693. doi: 10.3390/cells12232693.
7
Unraveling the epigenetic landscape of pulmonary arterial hypertension: implications for personalized medicine development.解析肺动脉高压的表观遗传学景观:对个体化医学发展的启示。
J Transl Med. 2023 Jul 17;21(1):477. doi: 10.1186/s12967-023-04339-5.
8
Pathophysiology and new advances in pulmonary hypertension.肺动脉高压的病理生理学与新进展
BMJ Med. 2023 Mar 23;2(1):e000137. doi: 10.1136/bmjmed-2022-000137. eCollection 2023.
9
Histone lactylation driven by mROS-mediated glycolytic shift promotes hypoxic pulmonary hypertension.组蛋白乳酰化驱动 mROS 介导的糖酵解转移促进低氧性肺动脉高压。
J Mol Cell Biol. 2023 Apr 20;14(12). doi: 10.1093/jmcb/mjac073.
10
Disrupted establishment of anaerobe and facultative anaerobe balance in preterm infants with extrauterine growth restriction.宫外生长受限早产儿需氧菌与兼性厌氧菌平衡建立受阻。
Front Pediatr. 2022 Sep 6;10:935458. doi: 10.3389/fped.2022.935458. eCollection 2022.